Submitted by Anonymous (not verified) on 28 January 2026 - 11:18
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 4, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jaypirca, pirtobrutinib, Date of authorisation: 30/10/2023, Revision: 4, Status: Authorised